Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E68.04 EPS (ttm)0.82 Insider Own0.50% Shs Outstand2.62B Perf Week0.96%
Market Cap145.08B Forward P/E21.72 EPS next Y2.56 Insider Trans0.00% Shs Float2.60B Perf Month-1.94%
Income2.15B PEG3.53 EPS next Q0.51 Inst Own17.60% Short Float0.16% Perf Quarter6.77%
Sales25.70B P/S5.65 EPS this Y-39.70% Inst Trans-3.57% Short Ratio0.63 Perf Half Y37.84%
Book/sh4.66 P/B11.94 EPS next Y30.77% ROA3.60% Target Price59.10 Perf Year23.22%
Cash/sh2.35 P/C23.72 EPS next 5Y19.30% ROE17.80% 52W Range36.15 - 64.94 Perf YTD11.63%
Dividend1.40 P/FCF- EPS past 5Y1.00% ROI8.30% 52W High-16.28% Beta0.52
Dividend %2.52% Quick Ratio0.60 Sales past 5Y-1.70% Gross Margin80.30% 52W Low50.40% ATR1.17
Employees70600 Current Ratio0.80 Sales Q/Q7.80% Oper. Margin14.90% RSI (14)44.35 Volatility1.70% 1.82%
OptionableYes Debt/Eq1.61 EPS Q/Q481.10% Profit Margin8.40% Rel Volume0.53 Prev Close55.66
ShortableYes LT Debt/Eq1.28 EarningsJul 30 BMO Payout0.00% Avg Volume6.52M Price54.37
Recom1.60 SMA20-1.40% SMA50-2.95% SMA2006.14% Volume2,708,423 Change-2.32%
Nov-22-19Initiated SVB Leerink Outperform
Oct-25-19Upgrade Liberum Hold → Buy
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-24-20 12:14PM  
11:33AM  
10:52AM  
07:52AM  
05:47AM  
03:58AM  
Sep-23-20 04:20PM  
02:31PM  
02:13PM  
11:06AM  
10:52AM  
10:51AM  
08:52AM  
06:45AM  
03:50AM  
Sep-22-20 05:45PM  
05:19PM  
11:21AM  
08:35AM  
07:59AM  
06:30AM  
Sep-21-20 04:31PM  
11:01AM  
10:35AM  
08:00AM  
06:16AM  
05:35AM  
03:08AM  
02:19AM  
Sep-20-20 12:30PM  
08:23AM  
06:09AM  
Sep-19-20 06:28PM  
01:04PM  
08:55AM  
06:15AM  
Sep-18-20 04:44PM  
03:57PM  
03:27PM  
03:12PM  
02:50PM  
02:36PM  
01:58PM  
01:05PM  
12:47PM  
12:11PM  
11:12AM  
09:51AM  
09:36AM  
09:26AM  
08:58AM  
08:00AM  
06:08AM  
Sep-17-20 05:48PM  
05:02PM  
04:54PM  
04:16PM  
03:55PM  
03:29PM  
11:06AM  
Sep-16-20 09:49PM  
04:43PM  
03:54PM  
02:04PM  
01:45PM  
08:33AM  
08:26AM  
02:24AM  
Sep-15-20 10:44PM  
10:43PM  
09:57PM  
09:01PM  
03:49PM  
03:24PM  
01:56PM  
01:11PM  
11:44AM  
11:10AM  
10:32AM  
05:40AM  
02:03AM  
12:15AM  
Sep-14-20 11:17PM  
10:46PM  
09:05PM  
04:34PM  
04:27PM  
04:15PM  
04:04PM  
04:00PM  
03:47PM  
03:41PM  
03:38PM  
03:16PM  
02:15PM  
01:09PM  
12:48PM  
12:48PM  
11:59AM  
11:58AM  
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 07Buy19.00425,0008,075,00014,650,334Oct 09 04:53 PM